Epstein-Barr virus serology in nasopharyngeal carcinomas and other head and neck neoplasms in Italy.
This paper reports the results of the EBV-specific antibody response in 17 Italian nasopharyngeal carcinoma (NPC) patients, 15 other head and neck tumor patients and 15 normal controls. Nucleic acid hybridization has been performed on the biopsy tissue from 4 of the NPC patients, and EBV-DNA was present in two undifferentiated (WHO 3) tumors, and absent in two samples of the keratinizing (WHO 1) type. EBV serology appears to be specifically related to NPC, more evidently for VCA-IgA and EA-IgG antibodies, and useful as an aid in diagnosis of NPC. However, in order to assess a prognostic value of the above markers, a greater number of patients followed for a longer period of time (at least 5 years) is needed, and is currently being pursued.
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D001706:Biopsy; D002213:Capsid / Q000276:immunology; D002648:Child; D005260:Female; D006258:Head and Neck Neoplasms / Q000382:microbiology*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007558:Italy; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000382:microbiology*; D009693:Nucleic Acid Hybridization
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G